Knight Therapeutics’ (TSE:GUD) “Outperform” Rating Reaffirmed at Raymond James Sundance Herald
Knight Therapeutics (TSE:GUD)’s stock had its “outperform” rating reiterated by analysts at Raymond James in a research note issued to investors on Thursday, …